6640--LONG TERM PROCUREMENT - BASE PLUS 4 INC. Cost Per Test Contract Immunoassay Tests for Portland VAMC
ID: 36C26025Q0624Type: Presolicitation
AwardedJul 16, 2025
AwardeeDIASORIN INC STILLWATER 55082
Award #:36C26025D0040
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF260-NETWORK CONTRACT OFFICE 20 (36C260)VANCOUVER, WA, 98661, USA

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

LABORATORY EQUIPMENT AND SUPPLIES (6640)

Original Source

https://sam.gov/opp/fbee5b625d134a888d7ac2cb2074571e/view
Timeline
    Description

    The Department of Veterans Affairs is seeking proposals for a long-term procurement contract for cost per test immunoassay tests at the Portland Veterans Affairs Medical Center (VAMC). This contract, identified by solicitation number 36C26025Q0624, aims to ensure the provision of essential diagnostic services that support the healthcare needs of veterans. The procurement is part of the VA's commitment to maintaining high-quality healthcare services through efficient and effective supply chain management. Interested parties should note that the deadline for submitting offers has been extended to July 3, 2025, at 5:00 PM PDT, and may contact Contracting Specialist Hector Gonzalez at hector.gonzalez1@va.gov for further information.

    Point(s) of Contact
    Hector GonzalezContracting Specialists
    hector.gonzalez1@va.gov
    Files
    Title
    Posted
    36C26025Q0624_1.docx
    This presolicitation notice details a long-term procurement opportunity for the cost per test contract related to immunoassay tests at the Portland Veterans Affairs Medical Center (VAMC). The contract, identified by solicitation number 36C26025Q0624, is set to be solicited by June 30, 2025, at 17:00 Pacific Time. The contracting office, located in Vancouver, WA, is under the jurisdiction of Network Contracting Office 20. The pertinent service code is 6640, with the NAICS code listed as 325413, indicating the specific industry sector for biopharmaceutical testing. Interested parties can contact Contracting Specialist Hector Gonzalez via email for more information. This opportunity underscores the VA's commitment to maintaining quality healthcare services for veterans through efficient procurement processes and is part of broader federal initiatives to enhance healthcare services and management within VA facilities.
    36C26025Q0624 0001.docx
    This government document serves as an amendment to a solicitation regarding the Base Plus 4 CPT Immunoassay Contract for the Portland VA Medical Center. The primary purpose of this amendment is to extend the deadline for receiving offers from June 30, 2025, to July 3, 2025, at 5:00 PM PDT. The contracting office, Network Contracting Office 20, is responsible for the administration of this solicitation. Potential offerors are required to acknowledge receipt of this amendment, which can be done by updating specific sections of their submission or through separate communication referencing the solicitation and amendment numbers. The amendment is a procedural adjustment, maintaining all previous terms and conditions of the original solicitation while informing bidders about the new deadline. Overall, this document illustrates a typical process in federal contracting, ensuring transparency and facilitating participation from various bidders while adhering to regulatory requirements set forth by the Federal Acquisition Regulation (FAR).
    S02-36C26025Q0624.docx
    The document outlines a Request for Proposal (RFP) issued by the Network Contracting Office 20 for an Indefinite Delivery Indefinite Quantity (IDIQ) contract concerning the supply of immunoassay instruments and related testing services to the Portland VA Medical Center. The contract spans five ordering periods from August 1, 2025, to July 31, 2030, with a guaranteed minimum of $500 and a maximum contract capacity of $1.5 million. The contractor is responsible for supplying all necessary reagents, maintaining equipment, offering training for personnel, and providing advanced customer support. Compliance with Federal Acquisition Regulation (FAR) clauses is mandatory, as well as adherence to technical industry standards. Key requisites include a 98% operational uptime guarantee for the instruments, timely delivery of supplies, rigorous training for staff, and stringent maintenance protocols. The purpose of this RFP is to enhance diagnostic capabilities at the Portland VA, ensuring high-quality patient care through reliable laboratory services and adherence to federal contracting regulations.
    Similar Opportunities
    Distribution of CPRR Immunoassays for BioRad BioPlex Lab Tests.
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking a contractor to provide the distribution of BioRad BioPlex laboratory reagents for the Seattle VA Medical Center. The procurement aims to establish a five-year Indefinite Delivery Indefinite Quantity (IDIQ) contract for automated immunoassay instrumentation capable of performing a variety of diagnostic tests, including those for autoimmune diseases and infectious agents. These reagents and instruments are critical for enhancing laboratory capabilities in diagnosing and managing patient care within the VA system. Interested small businesses must submit their quotes by December 19, 2025, at 17:00 Pacific Time, and can direct inquiries to Hector Gonzalez at hector.gonzalez1@va.gov or by phone at 360-553-7632.
    Q301--Biodesix, Inc. (621 II) (PENDING PROPOSAL)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for reference laboratory services under the Federal Supply Schedule (FSS) program, specifically for medical laboratory testing related to the diagnosis, prevention, or treatment of diseases. The procurement aims to establish contracts for domestic delivery of medical laboratory services, ensuring compliance with all relevant state, federal, and local regulations, including necessary licenses and permits for testing services. This opportunity is critical for enhancing patient care through accurate diagnostic testing, with the expectation that offerors will provide new items only, adhering to FDA regulatory requirements. Interested vendors can contact the FSS Help Desk at Fss.Help@va.gov or call 708-786-7737 for further details, as the solicitation is currently pending and specific deadlines for proposal submissions will be outlined in the official solicitation documents.
    Distribution of Biorad Bioplex Reagents and Consumables for Laboratory Tests.
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 20, is seeking a qualified contractor for a five-year Indefinite Delivery Indefinite Quantity (IDIQ) contract focused on the distribution of BioRad BioPlex reagents and consumables for laboratory tests at the Seattle VA Medical Center. The contractor will be responsible for supplying FDA-approved equipment, reagents, controls, calibrators, and all necessary consumables, along with installation, validation, technical support, preventative maintenance, and staff training, ensuring compliance with specific performance requirements such as rapid analysis and automated calibration. This procurement is critical for enhancing patient care through immunoassays that diagnose various health conditions, including infectious diseases and autoimmune disorders. Quotes are due by December 19, 2025, at 17:00 Pacific Time, and interested parties can contact Hector Gonzalez at hector.gonzalez1@va.gov or by phone at 360-553-7632 for further information.
    6550--HEMOCHRON SIGNATURE ELITE REAGENTS BASE PLUS 4 OPTION YEARS
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking proposals for the procurement of Hemochron Signature Elite Reagents, with a contract term of one base year and four option years, to support the Southern Arizona Healthcare System in Tucson, Arizona. The procurement includes a variety of specialized medical testing supplies essential for blood coagulation testing, with specific brand-name products required, as detailed in the attached documents. Timely delivery and compliance with FDA standards are critical, as these reagents will be used for patient testing in a healthcare setting. Interested vendors must submit their quotations by December 9, 2025, at 12 PM Pacific Time, and can direct inquiries to Contract Specialist Rebecca Gaba at Rebecca.Gaba@va.gov.
    6630--VISN 15 Automated Erythrocyte Sedimentation Rate Analyzers 36C255-26-AP-0538
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for an unrestricted solicitation for Cost-Per-Test (CPT) Blanket Purchase Agreements for Automated Erythrocyte Sedimentation Rate Analyzers intended for the VISN 15 Heartland Network Veterans Affairs Medical Centers (VAMCs). This procurement aims to enhance laboratory capabilities by providing essential equipment for conducting erythrocyte sedimentation rate tests, which are critical for diagnosing various medical conditions. The solicitation is expected to be released around December 19, 2026, with a response deadline set for January 12, 2026, at 10:00 AM Central Time. Interested parties can reach out to Contract Specialist Erika Kobulnicky at Erika.Kobulnicky@va.gov or by phone at 913-946-1991 for further information.
    6640--FY26| Thyroid Cancer Molecular Test| Orlando VA & San Juan New Requirement
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking to procure Thyroid Cancer Molecular Tests for the Orlando VA Healthcare System and Caribbean VA Healthcare System through a Firm-Fixed Price (FFP) contract. This procurement is designated as a Service-Disabled Veteran-Owned Small Business (SDVOSBC) set-aside, with the NAICS code 621511 and a small business size standard of $41.5 million. The solicitation is expected to be posted on sam.gov around December 15, 2025, with a response deadline of December 29, 2025, at 4:00 PM Eastern Time. Interested offerors must be registered in the System for Award Management (SAM) to be eligible for award, and for further inquiries, they can contact Yolanda Glover at yolanda.glover@va.gov or by phone at 352-381-5712.
    To Correct Description
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking responses to a Special Notice regarding a procurement opportunity related to medical laboratory testing services. Respondents are required to complete specific columns in the attached test list, particularly Columns D and E, which pertain to in-house testing capabilities and third-party courier services. This opportunity is crucial for ensuring the efficient provision of medical laboratory services, which play a vital role in supporting the healthcare needs of veterans. Interested parties should reach out to Eric A. Lingenfelter at Eric.Lingenfelter@va.gov or call 360-852-9891 for further details and to obtain the necessary documents for submission.
    To Correct Description
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking responses to a Special Notice regarding a procurement opportunity related to medical laboratory testing services. Respondents are required to complete specific columns in the attached test list, particularly Columns D and E, which pertain to in-house testing capabilities and third-party courier services. This opportunity is crucial for ensuring the availability and accuracy of medical laboratory tests, which play a vital role in patient care and treatment decisions. Interested parties should reach out to Eric A. Lingenfelter at Eric.Lingenfelter@va.gov or call 360-852-9891 for further details and to obtain the necessary documents for submission.
    Q301--Actionable-554 (LAB) | NEW - Prostate Testing, Urine, Non Invasive
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 19, is conducting a Sources Sought Notice to identify potential suppliers for Non-Invasive Prostate Testing Kits to support the Rocky Mountain Regional VA Medical Center. The procurement aims to acquire a urine-based molecular liquid biopsy test that differentiates between high and low risk of aggressive prostate cancer without using PSA levels or requiring a digital rectal exam (DRE). This testing is crucial for improving patient outcomes by providing accurate risk assessments for prostate cancer, thereby guiding the need for biopsies. Interested vendors must submit their capabilities, including company details and compliance with Federal Acquisition Regulation (FAR) requirements, by December 16, 2025, at 8:00 AM Eastern Time, to Alejandra Sierra at Alejandra.Sierra@va.gov.
    Q301--NEW - NTX Combined Reference Lab Testing (Anatomic, Surgical, Genetic) IDIQ
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking proposals for the NTX Combined Reference Lab Testing (Anatomic, Surgical, Genetic) IDIQ, aimed at providing laboratory testing services for the VA North Texas Healthcare System in Dallas, Texas. The contract will cover a range of services including tissue biopsies, surgical pathology, flow cytometry, and genetic analyses, with a performance period from April 1, 2026, to March 31, 2031, and four option years. This procurement is crucial for ensuring timely and accurate medical testing for veterans, with specific requirements including CLIA accreditation, HIPAA compliance, and secure electronic reporting. Interested vendors must submit their proposals by December 15, 2025, at 3:00 PM Eastern Time, and can direct inquiries to Contracting Officer Delphia Schoenfeld at delphia.schoenfeld@va.gov.